We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+13.22%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$174M
AUM Growth
+$14.4M
Cap. Flow
-$2.53M
Cap. Flow %
-1.45%
Top 10 Hldgs %
37.93%
Holding
107
New
5
Increased
18
Reduced
52
Closed
7

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$2.39M
2
BAM icon
Brookfield Asset Management
BAM
+$1.02M
3
EW icon
Edwards Lifesciences
EW
+$212K
4
QCOM icon
Qualcomm
QCOM
+$171K
5
SWK icon
Stanley Black & Decker
SWK
+$68.3K

Top Sells

Rank Stock Value
1
AMED
Amedisys
AMED
+$2.22M
2
BN icon
Brookfield
BN
+$1.13M
3
PARA
Paramount Global Class B
PARA
+$846K
4
ROG icon
Rogers Corp
ROG
+$242K
5
BAX icon
Baxter International
BAX
+$241K

Sector Composition

Rank Sector Weight
1 Healthcare 20.6%
2 Technology 18.9%
3 Industrials 18.17%
4 Financials 14.85%
5 Consumer Staples 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCSA icon
101
Comcast
CMCSA
$79.1B
– –
-5,834
Closed -$171K
D icon
102
Dominion Energy
D
$62.5B
– –
-768
Closed -$53K
NKE icon
103
Nike
NKE
$61.9B
– –
-550
Closed -$46K
PARA
104
DELISTED
Paramount Global Class B
PARA
– –
-44,445
Closed -$846K
PYPL icon
105
PayPal
PYPL
$49.5B
– –
-800
Closed -$69K
ROG icon
106
Rogers Corp
ROG
$2.33B
– –
-1,000
Closed -$242K
1 2 3 4
5

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q4 2022 Portfolio in Review

As of Q4 2022, Lipe & Dalton held 107 positions worth $174M, up 9% from $159M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Lipe & Dalton's Q4 2022 filing shows 5 new, 18 increased, 52 reduced and 7 closed positions. Its largest new stake was Moderna: 14,644 shares worth $2.63M. The largest sale was Amedisys, an estimated $2.22M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

  • Lipe & Dalton's largest Q4 2022 buy was Moderna: 14,644 shares worth $2.63M.
  • Lipe & Dalton added most to Qualcomm in Q4 2022, an estimated $171K increase.
  • Lipe & Dalton's biggest Q4 2022 reduction was Brookfield, cutting an estimated $1.13M.
  • Lipe & Dalton fully exited Amedisys in Q4 2022, selling an estimated $2.22M.
  • Lipe & Dalton's ten largest holdings make up 38% of its $174M portfolio in Q4 2022.
  • Lipe & Dalton opened 5 new positions and closed 7 in Q4 2022.
  • Lipe & Dalton's portfolio value rose 9% quarter-over-quarter to $174M.

Based on Lipe & Dalton's 13F filing for Q4 2022, filed 3 Feb 2023.